Page last updated: 2024-09-03

ezogabine and Neuralgia

ezogabine has been researched along with Neuralgia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amato, GS; Burns, JF; Eargle, CW; Fritch, PC; Harrison, W; Jones, L; McNaughton-Smith, G; Roeloffs, R; Wickenden, AD1
Boissard, CG; Bourin, C; Calandra, V; Chen, J; Chen, P; Conway, CM; Davis, CD; Dworetzky, SI; Fitzpatrick, W; Gribkoff, VK; Harden, DG; He, H; Heman, K; Knox, RJ; Machet, F; Natale, J; Polino, JL; Starrett, JE; Sun, LQ; Thompson, MW; Weaver, D; Wu, YJ1
Dang, D; Frost, JA; Li, J; Li, L; Yang, Q; Zuo, Y1
Bhatnagar, A; Garg, S; Kumar, A; Pottabathini, R1
Bernal, L; Lopez-Garcia, JA; Roza, C1
Blackburn-Munro, G; Jensen, BS1

Other Studies

6 other study(ies) available for ezogabine and Neuralgia

ArticleYear
Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain.
    Journal of medicinal chemistry, 2010, Jan-28, Volume: 53, Issue:2

    Topics: Adamantane; Animals; Azides; Epilepsy; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Mice; Neuralgia; Structure-Activity Relationship

2010
Discovery of (S,E)-3-(2-fluorophenyl)-N-(1-(3-(pyridin-3-yloxy)phenyl)ethyl)-acrylamide as a potent and efficacious KCNQ2 (Kv7.2) opener for the treatment of neuropathic pain.
    Bioorganic & medicinal chemistry letters, 2013, Nov-15, Volume: 23, Issue:22

    Topics: Acrylamides; Animals; KCNQ2 Potassium Channel; Male; Neuralgia; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley

2013
Activation of KCNQ Channels Prevents Paclitaxel-Induced Peripheral Neuropathy and Associated Neuropathic Pain.
    The journal of pain, 2019, Volume: 20, Issue:5

    Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carbamates; Cell Line, Tumor; Drug Repositioning; Humans; KCNQ Potassium Channels; Male; Neuralgia; Neurons; Neuroprotective Agents; Paclitaxel; Peripheral Nervous System Diseases; Phenylenediamines; Random Allocation; Rats, Sprague-Dawley

2019
Possible involvement of nitric oxide modulatory mechanism in the protective effect of retigabine against spinal nerve ligation-induced neuropathic pain.
    Cellular and molecular neurobiology, 2015, Volume: 35, Issue:1

    Topics: Animals; Carbamates; Ligation; Male; Neuralgia; Neuroprotective Agents; Nitric Oxide; Pain Threshold; Phenylenediamines; Rats; Rats, Sprague-Dawley; Spinal Nerves

2015
Spontaneous activity in C-fibres after partial damage to the saphenous nerve in mice: Effects of retigabine.
    European journal of pain (London, England), 2016, Volume: 20, Issue:8

    Topics: Action Potentials; Animals; Axotomy; Carbamates; Disease Models, Animal; Male; Membrane Transport Modulators; Mice; Nerve Fibers; Neuralgia; Neuroma; Peripheral Nerves; Phenylenediamines

2016
The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain.
    European journal of pharmacology, 2003, Jan-24, Volume: 460, Issue:2-3

    Topics: Animals; Anthracenes; Anticonvulsants; Behavior, Animal; Carbamates; Disease Models, Animal; Dose-Response Relationship, Drug; Hindlimb; Male; Neuralgia; Pain Measurement; Phenylenediamines; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Time Factors

2003